Abstract We determine the importance of indicators of nutrition including lymphocyte, total protein, albumin, cholinesterase and body mass index, and compare the prognostic significance in chronic heart failure (CHF). We examined consecutive 465 CHF patients (376 males, age 62 ± 14 years) who underwent cardiopulmonary exercise testing, echocardiography and blood examination including indicators of nutrition at the same time in our hospital. The patients were followed up [median period 766 days (interquartile range 500-1060)] to register cardiac deaths and rehospitalization due to worsening heart failure. There were 180 cardiac events during the follow-up periods. Patients with cardiac events had lower cholinesterase level than those without events (P \ 0.001). On the receiver operating characteristic analysis, the best cut-off value for cholinesterase was 240 U/l (area under the curve 0.720). In the Kaplan-Meier analysis, patients with cholinesterase \240 U/l had significantly higher cardiac event rates than those with cholinesterase [240 U/l. Multivariable Cox proportional hazards model demonstrated that NYHA class III [hazard ratio (HR): 1.688, 95 % confidence interval (CI) 1.062-2.684, P = 0.027], eGFR (HR: 0.983, 95 % CI 0.971-0.995, P = 0.006), sodium concentration (HR: 0.947, 95 % CI 0.897-0.999, P \ 0.046), log BNP (HR: 1.880, 95 % CI 1.509-2.341, P \ 0.001), cholinesterase (HR: 0.996, 95 % CI 0.993-0.998, P = 0.002) and exertional periodic breathing (HR: 1.619, 95 % CI 1.098-2.388, P = 0.015) were independent factors to predict adverse clinical outcomes. Serum cholinesterase level was an important prognostic factor in CHF.
Introduction
Many factors including cardiac functional parameters, exercise capacity, pulmonary function, biomarkers from blood and urine samples, and other clinical characteristics have determined the prognosis of patients with chronic heart failure (CHF) [1] [2] [3] . Cardiac cachexia is a critical state in CHF [4] . It has been reported that indicators associated with nutrition such as body mass index, total cholesterol, lymphocyte count and albumin are strong prognostic factors [5] [6] [7] . On the other hand, serum cholinesterase level is well known to be the most important prognostic factor in liver cirrhosis. Malnutrition and advanced liver dysfunction lead to low cholinesterase. However, the impact of cholinesterase in CHF has not been examined. Therefore, the purpose of this study was to determine the importance of indicators of nutrition including lymphocyte, total protein, albumin, cholinesterase and body mass index, and compare the prognostic significance in CHF.
Methods

Study subjects and study protocol
We examined 465 consecutive patients admitted to Fukushima Medical University Hospital for treatment of worsening CHF between July 2006 and May 2011. Written informed consent was obtained from all study subjects. Our study complies with the Declaration of Helsinki, and the study protocol was approved by the ethical committee of the Fukushima Medical University. We diagnosed CHF based on the Framingham criteria including symptoms, physical examinations, chest X-ray, and echocardiographic findings. All patients received optimal medications and were in stable condition before discharge. They underwent echocardiography and cardiopulmonary exercise testing at stable condition on the same day before discharge. Blood samples were obtained just prior to cardiopulmonary exercise testing.
There were 376 males and 89 females, mean age 61.2 ± 14.0 years. Baseline clinical characteristics of study subjects are shown in Table 1 . Exclusion criteria of the present study were decompensated heart failure after treatment, end-stage renal disease (estimated glomerular filtration rates [eGFR] \ 15 ml/min/1.73 m [2] ), liver diseases and malignant diseases. The eGFR was defined from the modification of diet in renal disease (MDRD) equation in Japan (recommendation of Japanese Society of Nephrology).
Patients were followed up after discharge to register cardiac events. The endpoints were cardiac death (death due to HF and sudden cardiac death) and rehospitalization due to worsening heart failure. The median follow-up period was 766 days (interquartile range 500-1060) and was completed for all patients. Events were adjudicated using medical records, death certificates, and a questionnaire method for home doctors.
We compared blood sampling data including indicators of nutrition (total cholesterol, total protein, albumin, cholinesterase, and lymphocyte), renal function, B-type natriuretic peptide (BNP), exercise capacity, and systolic and diastolic function.
Cardiopulmonary exercise testing
All subjects performed incremental symptom-limited exercise testing using an upright cycle ergometer with a ramp protocol (Strength Ergo 8, Fukuda Denshi Co. Ltd., Tokyo, Japan). Breath-by-breath oxygen consumption (VO 2 ), carbon dioxide production (VCO 2 ) and minute ventilation (VE) were measured during exercise using AE-300S respiratory monitor (Minato Medical Science, Osaka, Japan). Peak VO 2 was measured as an average of the last 30 s of exercise. Ventilatory response to exercise (expressed as a VE/VCO 2 slope) was calculated as the regression slope relating VE to CO 2 from the start of exercise until the respiratory compensation point (the time at which ventilation is stimulated by CO 2 output and end-tidal CO 2 tension begins to decrease) [8, 9] . In addition, exertional periodic breathing, a previously reported strong prognostic factor, was examined [10] .
Echocardiography
Left ventricular end-diastolic and end-systolic volumes (LVEDV and LVESV) and left ventricular ejection fraction (LVEF) were measured by the modified Simpson's method. Standard measurements of left atrial diameter (LAD) were also obtained in the parasternal long axis view [11] . Pulsed-wave Doppler recordings of the mitral flow velocity at the tip of mitral leaflets were obtained from the apical 4-chamber view during quiet respiration. From the Doppler profile, peak velocities of the early (E) wave and late (A) wave were calculated, together with the deceleration time of the E wave (DcT), taken as the time interval between the peak E wave and the zero intercept of the slope of the deceleration profile [12] . Inferior vena cava (IVC) dimension was measured in the supine position. Right ventricle systolic pressure (RVSP) was estimated using the simplified Bernoulli equation: 4(V TR ) 2 ? right atrial pressure (RAP), where V TR represents peak tricuspid regurgitation velocity [13] . Examination of the caliber and respiratory response of IVC were used to estimate RAP [14] . From the tissue-Doppler imaging, the mitral annulus velocity (E 0 ) was measured and the ratio of peak E wave velocity to E 0 wave velocity (E/E 0 ) was accepted for analysis. Heart failure with preserved ejection fraction (HFPEF) was defined as LVEF [50 % according to the ESC statements [15] .
Statistical analysis
Results are presented as mean ± SD for continuous variables and as numbers and percentages for categorical variables. Student's t test was used to compare continuous variables. If data were not distributed normally, the MannWhitney U test was used. The Chi square test was performed to compare categorical variables. A P value \ 0.05 was considered statistically significant. We then checked for the assumption of linearity of hazard requested by a restricted cubic spline Cox proportional hazard model [16] . The Cox proportional hazard regression models determined which variables were associated with cardiac events. We entered 24 variables (age, gender, body mass index, NYHA class, blood urea nitrogen, eGFR, sodium concentration, hemoglobin concentration, uric acid level, plasma BNP, total protein, albumin, total cholesterol, lymphocyte count, cholinesterase, LVEF, LAD, DcT, E/E 0 , RVSP, IVC, peak VO 2 , VE/VCO 2 and exertional periodic breathing) into the multivariable model. The cardiac event-free rates were calculated using the Kaplan-Meier analysis, and the logrank test was used to compare the results. The receiver Heart Vessels (2015) 30:204-210 205 NYHA New York heart association, eGFR estimated glomerular filtration rate, BNP B-type natriuretic peptide, LVEF left ventricular ejection fraction, LVEDV left ventricular end-diastolic volume, LVESV left ventricular end-systolic volume, LAD left atrial dimension, DcT deceleration time, E/E 0 ratio of mitral peak velocity of early filling (E) to early diastolic annular mitral velocity (E 0 ), RVSP right ventricular systolic pressure, IVC inferior vena cava Peak VO 2 peak O 2 uptake, VE/VCO 2 slope rate of increase in ventilation per unit increase in carbon dioxide production, ACE angiotensin-converting enzyme, ARB angiotensin-receptor blocker operating characteristic curve was constructed to determine the cut-off values. The increase in discriminative value of each variable for cardiac event rates was assessed by the integrated discrimination improvement (IDI) [17] . This determines the difference in the probability of patients belonging to predefined risk categories before and after the addition of variables. We evaluated the contribution of serum cholinesterase combined on reclassification as compared with a basic model that included clinical risk factors. Statistical analyses were performed using SPSS statistics software, version 21.0 (SPSS Inc, Chicago, IL), SAS software version 9.3 (SAS Institute, Inc., Cary, NC).
Results
Clinical characteristics of the study subjects
Clinical characteristics of the study subjects are shown in Table 1 . The average age of patients was 62; 80.9 % was male, 37 % had ischemic etiology, and 25 % had atrial fibrillation. Laboratory data, echocardiographic findings and results of cardiopulmonary exercise testing are shown in Table 1 . Average LVEF was 45 %. The number of patients with reduced ejection fraction (LVEF \50 %) was 292 (62.8 %), and that with preserved ejection fraction (LVEF [50 %) was 173 (37.2 %). From the data of cardiopulmonary exercise testing, exercise capacity was relatively preserved.
Comparisons of clinical characteristics and functional data between patients with and without cardiac events in CHF During follow-up period [median 766 days (interquartile range, 500-1060)], a total of 180 cardiac events were registered, including 58 cardiac deaths and 122 rehospitalizations due to worsening heart failure. Clinical characteristics, laboratory, echocardiographic and cardiopulmonary exercise testing data were compared between patients with and without cardiac events as shown in Table 1 . Patients with cardiac events had higher frequencies of atrial fibrillation. In the cardiac events group, body mass index was significantly lower than in those with no cardiac events. Patients with cardiac events had lower hemoglobin concentrations, higher concentrations of blood urea nitrogen, creatinine and uric acid, lower eGFR, and higher plasma BNP levels than those without events. In addition, patients with cardiac events had lower levels of serum cholinesterase, albumin, total cholesterol and lymphocyte counts. In echocardiographic data, patients with cardiac events had lower LVEF, larger LVEDV, LVESV, LAD, IVC, shorter DcT, higher E/E 0 , RVSP and IVC compared to those without cardiac events. In cardiopulmonary exercise testing, patients with cardiac events had lower peak VO 2 , and higher VE/VCO 2 slope than those without cardiac events. In addition, patients with cardiac events had higher frequencies of exertional periodic breathing than those without events.
Prognostic factors in study subjects
The ability of variables to predict cardiac events in this study was examined by the univariable and multivariable Cox proportional hazards analyses ( Table 2 ). The univariable analysis revealed significant association of age, body mass index, NYHA class III, blood urea nitrogen, eGFR, sodium, hemoglobin, uric acid, log BNP, serum cholinesterase level, total protein, albumin, total cholesterol, lymphocyte counts, LVEF (below 58 %), LAD, DcT, E/E', RVSP, IVC, peak VO 2 , VE/VCO 2 slope, and exertional periodic breathing with cardiac events. The regression spline graph suggested that there appeared to be a linear increase in hazard for adverse cardiac events as decreasing serum cholinesterase level (Fig. 1 ). These variables with P value 
Prognostic impact of cholinesterase in CHF
On the receiver operating characteristic analysis (Fig. 2a) , the best cut-off value for cholinesterase to identify patients with cardiac events was 240 U/l (sensitivity: 0.594; specificity: 0.702; area under the curve (AUC): 0.720, P \ 0.001). In the Kaplan-Meier analysis, patients with serum cholinesterase level \240 U/l had significantly higher cardiac event rates than those with cholinesterase [240 U/l (Fig. 2b) . In addition, ChE was a more accurate predictor of outcomes than any nutritional variables as previously reported in CHF ( Table 2 ). The introduction of cholinesterase improved prognostic discrimination for adverse cardiac events, estimated with IDI, and compare with a model that included only clinical risk factors that emerged in the reduced model (IDI, 0.015; P = 0.020).
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Discussion
Among known prognostic factors such as levels of sodium, BNP, peak VO 2 and exertional periodic breathing, cholinesterase was an independent factor for predicting cardiac events in CHF. In the present study, body mass index, albumin, total cholesterol, cholinesterase and lymphocyte counts were lower in patients with cardiac events than in those without events, suggesting that malnutrition is an important feature in CHF. Furthermore, we demonstrated using the Cox proportional hazards regression analyses that serum cholinesterase level was an independent factor for predicting cardiac events among parameters of laboratory data, cardiac function and exercise capacity.
Malnutrition and CHF
Malnutrition, cardiac cachexia and wasting have been reported as prognostic factors in CHF [5, 6, 7] . One of the mechanisms of wasting is explained by the activation of inflammatory cytokines (e.g., tumor necrosis factor (TNF)-a,) [18] . Circulating levels of TNF-a are elevated in a severe state of CHF [19] , and highly elevated TNF-a concentration leads to ''cachexia'' in CHF patients [20] . However, we were unable to measure TNF-a and other inflammatory cytokines in the present study, and these should be measured in a future study. Whether interventions of nutrition for patients with CHF lead to favorable outcomes is fully unknown [21] . We therefore should pay more attention to nutritional conditions in CHF and discuss whether improved nutritional state improves clinical outcomes.
Impact of serum cholinesterase in CHF
Cholinesterase is an enzyme capable of hydrolyzing a variety of choline esters. It is produced by the liver, and serum levels fall when liver diseases decrease protein synthesis [22] . The changes generally parallel those seen with indicators of nutrition. Chronic hepatitis and liver Other abbreviations as in Table 1 HR hazard ratio, CI confidence interval cirrhosis are accompanied by low levels of cholinesterase. Cholinesterase has been used to assess liver function before and after hepatic transplantation [20] . Moreover, cholinesterase has the best prognostic value in liver diseases. As previously reported, liver functional abnormalities are common during acute decompensated heart failure [22] . Especially, changes in albumin and total bilirubin provide additional prognostic value during hospitalization. However, parameters of the other liver function did not predict prognosis in acute decompensated heart failure and after treatment of acute heart failure [23] . On the other hand, the present study showed that cholinesterase was an independent factor to predict adverse events in CHF. On the receiver operating characteristic analysis, serum ChE level had highly specific and low sensitive value in CHF. Thus, lower serum ChE level may lead to higher adverse cardiac event rate, but higher ChE may not always lead to lower cardiac event rate. Although liver function in CHF has not been fully examined, cardio-hepatic interaction may be important in CHF [24] .
Study limitations
This study was performed in a single center, and may not reflect the general population of patients with CHF. All subjects in this study performed cardiopulmonary exercise testing, and CHF patients who could not perform exercise testing were excluded. Thus the study subjects were a relatively younger population and had preserved exercise tolerance suggesting that their cardiac event rates might be lower than those previous studies reported. Consequently, our results might not be fully applied to patients with more advanced cardiac dysfunction. Generally, renal dysfunction leads to highly elevated serum cholinesterase. Thus, our conclusions might not be fully applied to patients with severe renal dysfunction, as patients with end-stage renal disease were excluded.
Conclusions
Cholinesterase, a simple measure of nutrition, was an independent factor for predicting cardiac events in CHF. Therefore, we should pay more attention to serum cholinesterase levels when treating CHF patients. 
